Researchers at University College London (UCL) have discovered that combining cerebrospinal fluid (CSF) testing with MRI scans could provide an early indication of a person’s risk of developing Alzheimer’s.
It is thought that this approach could enable testing of treatments or preventions far earlier in the disease.